{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"pt-141-trigeminal","urls":{"read":"https://miscsubjects.com/api/articles/pt-141-trigeminal/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/pt-141-trigeminal/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/pt-141-trigeminal/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/pt-141-trigeminal/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/pt-141-trigeminal/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/pt-141-trigeminal/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/pt-141-trigeminal/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"pt-141-trigeminal","title":"PT-141 for Trigeminal: Evidence Review","register":"source_ledger","tags":["peptide","matrix"],"updated_at":"2026-07-17T02:41:12.325Z","body_excerpt":"## What's breaking down\n\nTrigeminal issues often involve degeneration in the trigeminal nerve or its central processing pathways. This can include nerve fiber damage, inflammation around the nerve root, or changes in how the brain handles signals from the face. When breakdown outruns repair, pain or altered sensation can persist. The provided peptide chain focuses on a sexual / CNS arousal layer rather than direct nerve repair.\n\n## Why PT-141 might help you\n\n1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 acts as a melanocortin receptor agonist primarily on MC4R in the central nervous system. This central action is tied to arousal pathways in the hypothalamus. If CNS arousal components overlap with your trigeminal presentation, the discussion centers on potential tissue-level effects rather than symptom suppression alone.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **PT-141** → sexual / CNS arousal\n\n## What the evidence actually shows\n\nNo human trials link PT-141 directly to trigeminal conditions (preclinical tier absent; human tier: none found). All identified human data address hypoactive sexual desire disorder via central melanocortin activation. Animal and mechanistic data focus on sexual response pathways.\n\n## What scientists say\n\nResearchers describe PT-141 as a melanocortin agonist that stimulates central pathways for arousal independent of vascular effects. No published statements address trigeminal applications.\n\n## What people say on Reddit\n\nNo specific anecdotes tying PT-141 to trigeminal symptoms appear in available discussions. General peptide conversations center on sexual effects.\n\n## What people say on X\n\nNo posts identified connecting PT-141 use to trigeminal neuralgia or related pain.\n\n## What we do not know\n\nDirect evidence for PT-141 in trigeminal degeneration layers remains absent. Any overlap with CNS arousal pathways or intranasal delivery routes (which can involve trigeminal nerves for CNS access) is mechanistic only and untested for this use.\n\n## Safety and limits\n\nPT-141 carries known side effects in its approved context, including nausea and blood pressure changes. Application to trigeminal concerns lacks safety data. All discussion stays within repair-versus-degeneration framing without implying treatment.","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[{"id":"c1","text":"PT-141 (bremelanotide) is a melanocortin receptor agonist acting primarily on MC4R in the CNS to influence arousal pathways.","tier":"mechanistic","weight":0.3,"section":"Why PT-141 might help you","slot":null,"interaction_risk":false,"status":"active","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes the core mechanism referenced in the peptide chain.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c2","text":"No human clinical trials examine PT-141 for trigeminal neuralgia or related conditions.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s2"],"source_status":"sourced","why_material":"Confirms absence of direct evidence for the condition.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c3","text":"Intranasal delivery of melanocortin peptides like PT-141 can involve trigeminal nerve pathways to reach the CNS.","tier":"mechanistic","weight":0.3,"section":"What we do not know","slot":null,"interaction_risk":false,"status":"active","source_ids":["s3"],"source_status":"sourced","why_material":"Notes the only trigeminal-related mechanistic link found.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true}],"sources":[{"id":"s1","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2694735/","title":"Melanocortin Receptors, Melanotropic Peptides and Penile Erection","quote":"With its central mechanism of action, PT-141 may act independent or synergistically with PDE-5 inhibitors","summary":"Describes PT-141 central melanocortin action for sexual response.","claim_ids":["c1"],"link_status":"ok","quote_status":"verified","hash":"38a341bdef183a029fa322f24898518fb03557981be3c7b90fa610175215a474"},{"id":"s2","type":"review","url":"https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805","title":"Bremelanotide (subcutaneous route)","quote":"Bremelanotide injection is used to treat hypoactive sexual desire disorder (HSDD)","summary":"Approved use limited to HSDD; no trigeminal mention.","claim_ids":["c2"],"link_status":"http_403","quote_status":"unverified","hash":"c1b7a3cf80b240d3a1fa90007cf108d908349100c899c086129c04c1e4d9e972"},{"id":"s3","type":"other","url":"https://palmettopeptides.com/blogs/news/pt-141-vs-mt-2-melanocortin-research-comparison","title":"PT-141 vs MT-2 Melanocortin Research Comparison","quote":"The intranasal route is particularly relevant for CNS-targeted research with these compounds, as it facilitates delivery via the olfactory and trigeminal nerve pathways to the CNS","summary":"Mechanistic note on trigeminal involvement in delivery only.","claim_ids":["c3"],"link_status":"http_526","quote_status":"unverified","hash":"32e645dc3950a0fe817a8e785d4baa27953a23cf12e2c27c7fb71248d34f1da3"}],"anecdotal_sources":[],"scientific_sources":[{"id":"s1","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2694735/","title":"Melanocortin Receptors, Melanotropic Peptides and Penile Erection","quote":"With its central mechanism of action, PT-141 may act independent or synergistically with PDE-5 inhibitors","summary":"Describes PT-141 central melanocortin action for sexual response.","claim_ids":["c1"],"link_status":"ok","quote_status":"verified","hash":"38a341bdef183a029fa322f24898518fb03557981be3c7b90fa610175215a474"},{"id":"s2","type":"review","url":"https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805","title":"Bremelanotide (subcutaneous route)","quote":"Bremelanotide injection is used to treat hypoactive sexual desire disorder (HSDD)","summary":"Approved use limited to HSDD; no trigeminal mention.","claim_ids":["c2"],"link_status":"http_403","quote_status":"unverified","hash":"c1b7a3cf80b240d3a1fa90007cf108d908349100c899c086129c04c1e4d9e972"}],"user_reports":[],"related_articles":[],"question_graph":{"slug":"pt-141-trigeminal","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":3,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":3,"claims_total":3,"sources":3,"anecdotal":0,"scientific":2,"user_reports":0,"questions":0,"evidence_ingests":0}}